Summary
Module 15
This course will give you an understanding of the regulatory affairs environment for generic products and generic companies in the EU.
We will focus on the characteristics of generic products and the registration and marketing of generic products. You will also get an understanding of the differences between generic and originator applications.
You will be taken through the life-cycle of generic products from the development of the product through regulatory strategy, evaluation of the dossier and preparation of the marketing authorization application, as well as the post-authorization responsibilities linked to the product, such as pharmacovigilance and life cycle management.
In addition we will compare scenarios such as different challenges at the generic companies for own development products versus in-licensed products.
The module focuses on the current EU regulatory legislation and guidelines.
Keywords
- Definitions, requirements and socio-economics/ethics
- Challenges for generics
- Development of generic products
- Legal basis and procedures
- Strategy
- Application and content
- Clinical studies relevant for generics
- BE guidelines
- MAH responsibilities
- Future trends
- Advantages and challenges
Hi!
Do you need help choosing the right course?
We are ready to help you at +45 39 27 60 60 or contact@atriumcph.com
Save information for later
Course leader & lecturers
- Adrian AndrewsCourse leaderRegulatory Affairs Manager Hospitals
Teva Pharmaceuticals Europe - Malin FillerLecturerSenior Consultant Regulatory Affairs and Clinical Pharmacokinetics
SDS Life Science AB - Frank van StrienLecturerVice President Regulatory Affairs
Synthon Holding BV - Anna Rytter JoabssonLecturerSenior consultant Regulatory Affairs
SDS Life Science AB
Is this course for you?
This course is for you if you are an experienced Regulatory Affairs professional, employed in the industry, a regulatory agency, or a consulting firm.
What you will learn
- The background for generic products
- The possibilities in the legislation for obtaining marketing authorizations with abridged documentation
- How to advise and decide in bioequivalence studies
- How to analyze and evaluate on strategy and choice of regulatory procedure and reference product
What your company will get
- A regulatory professional who understands the characteristics of generic products
- A regulatory professional who can navigate within the regulatory affairs environment for generic products
- A regulatory professional who can advise and decide in bioequivalence studies
- An employee who can play an important strategic role in the analysis, evaluation and decision on regulatory procedure and reference product
Course calendar
Day 1
- Introduction • Setting the scene – authority point of view
- Setting the scene – industry point of view
- Legal basis and procedures
- Development of generic products Strategy
- Application and procedure
- Workshop Day 1 – Strategy
Day 2
- Clinical Studies
- BE guidelines
- Workshop Day 2 - Bioequivalence
- MAH responsibilities and cooperation with other functions – from a regulatory point of view
- Trends, future, advantages/ challenges
Registration
Registration deadline5 Oct 2023
Lersø Parkallé 101
2100 København Ø
Course information
Literature
Prior to the course you will get access to mandatory and optional readings via your personal Atrium log-in.
Please familiarize yourself with the mandatory readings before starting the course.
The mandatory readings are also part of the examination syllabus
Prerequisites
To enroll in this course, you must have a relevant educational background at bachelor level and experience in regulatory affairs or other equivalent qualifications. We consider all applications upon registration.
If you do not fulfill the requirements, you can still apply for the course if you have experience in the pharmaceutical/biological area that would allow you to benefit from the training and enable you to participate actively during the module. Up to 10% of the positions on our course are filled by applicants who have no or limited experience in regulatory affairs.
We consider applicants on a case-by-case basis.
Examination
The exam is held online, usually 4-6 weeks after the course.
You will receive a link with exam questions via your personal Atrium log-in.
In order to participate in the exam, you must have attended the course.
This course is a part of a diploma
The regulatory affairs diploma gives you an understanding of the entire regulatory affairs platform of the medicinal lifecycle. All courses have been designed in collaboration with highly acclaimed experts that are on our regulatory affairs Advisory Board.
Read moreCourse leader
Teva Pharmaceuticals Europe
Lecturers
SDS Life Science AB
Teva Pharmaceuticals Europe
Synthon Holding BV
SDS Life Science AB
You may also be interested in these courses
Want to know more or need help?
Contact Client Manager Mette Ribergaard Rasmussen at +45 39 15 09 30
Send me a message